Serum IGF-1 and IGFBP-3 Levels in Central Precocious Puberty Girls Treated with Gonadotropin Releasing Hormone Agonist (GnRHa).
Kyung Hee Yi
J Korean Soc Pediatr Endocrinol. 2011;16(1):20-23. DOI: https://doi.org/10.6065/jkspe.2011.16.1.20
|
Citations to this article as recorded by
Efficacy and safety of fermented oyster extract for height of children with short stature: A randomized placebo-controlled trial
Aram Jeong, Beom-Chan Park, Hee-Yeon Kim, Jun-Yong Choi, Jinhong Cheon, Joung-Hyun Park, Bae-Jin Lee, Kibong Kim
Integrative Medicine Research.2021; 10(2): 100691. CrossRef The alteration of IGF-1 levels and relationship between IGF-1 levels and growth velocity during GnRH analogue therapy
Nursel Muratoglu Sahin, Havva Nur Peltek Kendirci, Semra Çetinkaya, Şenay Savaş Erdeve, Zehra Aycan
Journal of Pediatric Endocrinology and Metabolism.2020; 33(1): 113. CrossRef Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy
Han Sol Song, Won Bok Choi, Joon Sup Song, Il Tae Hwang, Seung Yang
Annals of Pediatric Endocrinology & Metabolism.2014; 19(4): 208. CrossRef
|